Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia

被引：17
作者：
Perwein, Thomas [1 ]
Strehl, Sabine [2 ]
Koenig, Margit [2 ]
Lackner, Herwig [1 ]
Panzer-Gruemayer, Renate [2 ,3 ,4 ]
Mann, Georg [3 ,4 ]
Attarbaschi, Andishe
Urban, Ernst-Christian [1 ]
Haas, Oskar A. [2 ,3 ,4 ]
机构：
[1] Med Univ Graz, Div Pediat Hematol Oncol, Graz, Austria
[2] St Anna Kinderkrebsforsch, CCRI, Vienna, Austria
[3] St Anna Childrens Hosp, Vienna, Austria
[4] Med Univ Vienna, Vienna, Austria
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 08期
关键词：
acute lymphoblastic leukemia; RCSD1-ABL1-positive; relapse; long-term remission; imatinib; PH-LIKE; KINASE; PATIENT; FUSION; ABL1; GENE;
D O I：
10.3324/haematol.2015.139568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E332 / E335
页数：4
相关论文
共 15 条
  • [1] Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
    Collette, Y.
    Prebet, T.
    Goubard, A.
    Adelaide, J.
    Castellano, R.
    Carbuccia, N.
    Garnier, S.
    Guille, A.
    Arnoulet, C.
    Charbonier, A.
    Mozziconacci, M. J.
    Birnbaum, D.
    Chaffanet, M.
    Vey, N.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e292 - e292
  • [2] A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
    De Braekeleer, E.
    Douet-Guilbert, N.
    Le Bris, M-J
    Berthou, C.
    Morel, F.
    De Braekeleer, M.
    [J]. LEUKEMIA, 2007, 21 (10) : 2220 - 2221
  • [3] Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion
    De Braekeleer, E.
    Douet-Guilbert, N.
    Guardiola, P.
    Rowe, D.
    Mustjoki, S.
    Zamecnikova, A.
    Al Bahar, S.
    Jaramillo, G.
    Berthou, C.
    Bown, N.
    Porkka, K.
    Ochoa, C.
    De Braekeleer, M.
    [J]. LEUKEMIA, 2013, 27 (06) : 1422 - 1424
  • [4] ABL1 fusion genes in hematological malignancies: a review
    De Braekeleer, Etienne
    Douet-Guilbert, Nathalie
    Rowe, David
    Bown, Nick
    Morel, Frederic
    Berthou, Christian
    Ferec, Claude
    De Braekeleer, Marc
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (05) : 361 - 371
  • [5] The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias
    Duhoux, Francois P.
    Auger, Nathalie
    De Wilde, Sigrid
    Wittnebel, Sebastian
    Ameye, Genevieve
    Bahloula, Khadija
    Van den Berg, Catherine
    Libouton, Jeanne-Marie
    Saussoy, Pascale
    Grand, Francis H.
    Demoulin, Jean-Baptiste
    Poirel, Helene A.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (07) : E114 - E117
  • [6] A t(1;9)(q23.3∼q25;q34) affecting the ABL1 gene in a biphenotypic leukemia
    García, JRG
    Bohlander, SK
    Angulo, MG
    Flores, MAE
    Cárdenas, VJP
    Espinoza, JPM
    Madrigal, MDA
    Rivera, H
    [J]. CANCER GENETICS AND CYTOGENETICS, 2004, 152 (01) : 81 - 83
  • [7] Role of ABL family kinases in cancer: from leukaemia to solid tumours
    Greuber, Emileigh K.
    Smith-Pearson, Pameeka
    Wang, Jun
    Pendergast, Ann Marie
    [J]. NATURE REVIEWS CANCER, 2013, 13 (08) : 559 - 571
  • [8] Tyrosine Kinase Inhibitor Use in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Anemia
    Hunger, Stephen P.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 361 - 365
  • [9] RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations
    Inokuchi, Koiti
    Wakita, Satoshi
    Hirakawa, Tsuneaki
    Tamai, Hayato
    Yokose, Norio
    Yamaguchi, Hiroki
    Dan, Kazuo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (03) : 255 - 260
  • [10] Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI [10.1155/2014/357027, 10.1155/2014/852748]
12